STOCK TITAN

Insider sale notice: Justin Klee to sell 57,529 AMLX shares (NASDAQ: AMLX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Justin B. Klee filed a Form 144 proposing the sale of 57,529 common shares tied to the vesting of restricted stock units through Morgan Stanley Smith Barney LLC on 03/02/2026. The filing lists prior open‑market sales by Mr. Klee in January–February 2026, including sales of 136,193 shares on 01/15/2026 and 15,500 shares on 02/02/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the AMLX Form 144 disclose?

The Form 144 discloses a proposed sale of 57,529 common shares tied to RSU vesting through Morgan Stanley Smith Barney LLC on 03/02/2026. It also lists prior insider sales in January–February 2026 by Justin B. Klee.

Who is the reporting insider on the AMLX Form 144?

The reporting person is Justin B. Klee, with address information shown. The filing lists sales and the proposed transaction executed via Morgan Stanley Smith Barney LLC on 03/02/2026.

How many shares are proposed for sale in the AMLX filing?

The filing proposes the sale of 57,529 common shares associated with the vesting of restricted stock units on 03/02/2026. The transaction is presented as a brokered sale through Morgan Stanley Smith Barney LLC.

Does the Form 144 show recent insider sales for AMLX?

Yes; the filing lists prior sales by Justin B. Klee, including a sale of 136,193 shares on 01/15/2026 and a sale of 15,500 shares on 02/02/2026, among other January 2026 transactions.

Which broker is handling the proposed AMLX sale?

The proposed sale is listed as handled by Morgan Stanley Smith Barney LLC at 1 New York Plaza, with the transaction date shown as 03/02/2026 in the filing.
Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.55B
92.94M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE